Search Within

Rebecca Leboeuf

Formats
  1. Journal Article (10)
  2. Book Section (2)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (13)
  2. Division of Subspecialty Medicine (13)
  3. Endocrinology (13)
  4. Survivorship Research (12)
  5. GSK Faculty (7)
  6. Molecular Pharmacology and Chemistry Program Faculty (6)

More Groups

People
  1. Robert Tuttle (12)
  2. Steven Larson (5)
  3. James Fagin (4)
  4. Ashok Shaha (3)
  5. Keith Pentlow (3)
  6. Ravinder Grewal (3)

More People

Years
  1. 2013 (1)
  2. 2012 (1)
  3. 2010 (2)
  4. 2009 (3)
  5. 2008 (3)
  6. 2007 (2)

More Years

Publications
  1. Thyroid (5)
  2. Cancer Rehabilitation: Principles and Practice. 1st ed (1)
  3. Endocrine Surgery: Principles and Practice (1)
  4. Endocrinology and Metabolism Clinics of North America (1)
  5. Journal of Clinical Endocrinology and Metabolism (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Mary Ann Liebert, Inc (5)
  2. American Society of Clinical Oncology (1)
  3. Demos Medical Publications (1)
  4. Elsevier Inc. (1)
  5. Massachusetts Medical Society (1)
  6. Oxford University Press (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new American thyroid association staging system
    Journal Article

    Tuttle, R. M.; Tala, H.; Shah, J.; Leboeuf, R.; Ghossein, R.; Gonen, M.; Brokhin, M.; Omry, G.; Fagin, J. A.; Shaha, A.
    Thyroid (2010)

    Fulltext@MSK | Save
  • Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function
    Journal Article

    Tuttle, R. M.; Lopez, N.; Leboeuf, R.; Minkowitz, S. M.; Grewal, R.; Brokhin, M.; Omry, G.; Larson, S.
    Thyroid (2010)

    Fulltext@MSK | Save
  • Postoperative management of well-differentiated thyroid cancer
    Book Section

    Tuttle, R. M.; Leboeuf, R.
    In Hubbard, J. G. H.; Inabnet, W. B.; Lo, C. Y. (Eds.) Endocrine Surgery: Principles and Practice (2009)

    Fulltext@MSK | Save
  • Evaluation and treatment of thyroid cancer
    Book Section

    Tuttle, R. M.; Leboeuf, R.
    In Stubblefield, M. D.; O'Dell, M. W. (Eds.) Cancer Rehabilitation: Principles and Practice. 1st ed (2009)

    Fulltext@MSK | Save
  • Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation
    Journal Article

    Molinaro, E.; Leboeuf, R.; Shue, B.; Martorella, A. J.; Fleisher, M.; Larson, S.; Tuttle, R. M.
    Thyroid (2009)

    Fulltext@MSK | Save
  • Medical management of thyroid cancer: A risk adapted approach
    Journal Article

    Tuttle, R. M.; Leboeuf, R.; Shaha, A. R.
    Journal of Surgical Oncology (2008)

    Fulltext@MSK | Save
  • Follow up approaches in thyroid cancer: A risk adapted paradigm
    Journal Article

    Tuttle, R. M.; Leboeuf, R.
    Endocrinology and Metabolism Clinics of North America (2008)

    Fulltext@MSK | Save
  • BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines
    Journal Article

    Leboeuf, R.; Baumgartner, J. E.; Benezra, M.; Malaguarnera, R.; Solit, D.; Pratilas, C. A.; Rosen, N.; Knauf, J. A.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2008)

    Fulltext@MSK | Save